Dianosic
PrivateLast Round
Series A
Nov 3, 2025
Total Funding Raised
$1.63M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Dianosic operates in Healthcare & Life Sciences and is based in Strasbourg. Its latest recorded funding round was a VC Round in February 2023.
Dianosic is a medical technology company that develops innovative intranasal drug-delivery solutions and medical devices for the treatment of ENT conditions such as chronic rhinitis, sinusitis, and epistaxis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dianosic Comparables
Compare Dianosic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| S.T. Stent | 84% | |
| Medtronic | 82% | |
| Lyra Therapeutics | 77% |
For institutional investors. Book with your work email.
Dianosic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 3, 2025 | ||||
| VC Round | Feb 6, 2023 | ||||
| Seed | Apr 14, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Dianosic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fondation Force | VC Round |
| Noshaq | Series A |
| Caisse d'Epargne Grand-Est Europe | Seed |
| Finovam Gestion | Series A |
| Capital Grand Est | Series A |
| Région Grand Est | Seed |
| WiSeed | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 3, representing 21% of headcount.
- Jul 28, 2026
Monthly visitors grew 337% MoM, reaching 568.
For institutional investors. Book with your work email.
Dianosic Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dianosic's valuation, stock price, and market status.
Is Dianosic a public or private company?
Dianosic is a private company.
What is the current stock price of Dianosic?
Dianosic is a private company, so its shares have no public market price. Caplight tracks Dianosic's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dianosic worth (valuation)?
Valuation information for Dianosic is not publicly available.
Can I buy Dianosic stock?
Dianosic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dianosic's last funding round?
Dianosic's most recent funding round was Series A on November 3, 2025.
Who are the main investors in Dianosic?
Key investors in Dianosic include Fondation Force, Noshaq, Caisse d'Epargne Grand-Est Europe, Finovam Gestion, Capital Grand Est.
Will Dianosic IPO soon?
No public IPO plans have been announced for Dianosic.
How can I track Dianosic secondary market activity?
Caplight tracks bids, offers, and trades in Dianosic's shares on secondary markets.